| CARD ID | 209 | |
| Type of strain | Targeted mutant. | |
| Strain name | B10D2-Irf2tm1Isgf3gtm1 | |
| Internal Code | , B10D2-IRF9(p48)(-/-)IRF-2(-/-) | |
| Submitter | Unknown Unknown | |
| Submitter affiliation or code | ||
| Stock Type | ||
| Material Transfer Conditions |
Consent to us
|
|
| Production method | in-house breeding | |
| Origin (In-house) | Organization | |
| Organization code | ||
| Developer | ||
| Origin (From other organizations) | Organization | |
| Organization code | ||
| Developer | ||
| Year introduced | ||
| Introduced Generation | ||
| Remarks | ||
| Gene symbol | Irf2 |
| Gene name | Interferon regulatory factor 2 |
| Allele symbol | Irf2tm1 |
| Allele name | Irf2, targeted mutation 1 |
| MGI | MGI:96591, |
| Chromosome | 8 , |
| Gene classification | Targeted or trapped gene(knockout etc.) |
| Method | |
| GO | Gene Ontology |
| OMIM | OMIM ID: 147576 Human Gene Symbol: IRF2, |
| Gene symbol | Isgf3g (Irf-9, p48) |
| Gene name | interferon dependent positive acting transcription factor 3 gamma |
| Allele symbol | Isgf3gtm1 |
| Allele name | Isgf3g, targeted mutation 1 |
| MGI | MGI:107587, |
| Chromosome | 14 , |
| Gene classification | Targeted or trapped gene(knockout etc.) |
| Method | |
| GO | Gene Ontology |
| OMIM | OMIM ID: 147574 Human Gene Symbol: IRF9, |
| Author | Toshifumi Matsuyama, Tohru Kimura, Motoo Kitagawa, Klaus Pfeffer, Takatoshi Kawakami, Nobumasa Watanabe, Thomas M. Kundig, Ryuichi Amakawa, Kenji Kishihara, Andrew Wakeham, Julia Potter, Caren L. Furlonger, Arumugavadivel Narendran, Haruhiko Suzuki, Pamela S. Ohashi, Christopher J. Paige, Tadatsugu Taniguchi, and Tak W. Mak |
| Title | Targeted Disruption of IRF-1 or IRF-2 Results in Abnormal Type I IFN Gene Induction and Aberrant Lymphocyte Development |
| Journal | Cell |
| Volume | 75 |
| Page | 83-97 |
| Year | 1993 |
| PMID | 8402903 |
| Disease name, Applicable field |